Articles Vol. 65 No. CĐ10 - Bệnh viện Thống Nhất 30/10/2024

51. PRE-AND POST-VATS MEDIASTINAL LYMPH NODES ASSESSMENT OF EARLY STAGE NON-SMALL CELL LUNG CANCER AT THONG NHAT HOSPITAL

Do Kim Que1,2, Nguyen Do Nhan1,2
1 Thong Nhat Hospital
2 Bệnh viện Thống Nhất
Corresponding author: dokimque@gmail.com
DOI: 10.52163/yhc.v65iCD10.1639
22 Views
16 Downloads
Keywords
Non-Small Cell Lung Cancer (NSCLC) early stage thoracoscopy surgery
Abstract

Introdution: Non-small cell lung cancer (NSCLC) is frequently cancer and the leading cause death of cancer. Surgery is an effective treatment to the early stages. There are factors that help determine the stage, mediastinal lymph nodes play an important role so it is necessary to evaluate the characteristics of mediastinal lymph nodes and surgical results.

Methods: Retrospective of Early stage NSCLC cases with mediastinal lymph node evaluation underwent lobectomy (VATS) at Thong Nhat Hospital from January 2020 to January 2024.

Results: 51 patients. There are 32 males and 19 females, mean age is 59.1. There are 72.5% of patients had symptomatic disease; 100% had CT scan, 1 case had PET scan. 14 cases of lymph node dissection were seen during surgery. Before surgery: N1 lymph nodes were 11.7%, after surgery N1 lymph nodes were 11.7%, N2 lymph nodes were 11.7%.; Adenocarcinoma is 64.7%. The mean operating time is 119,2 ± 33,79 minutes. Hospitalization is 10,8 ± 02,1 days. 06 cases were converted to thoracotomy. Complications: pneumonia were 29.4%, prolonged air-leak 09.6%, pleeding 15,7% (01 case at the cut when using 1 stapler to cut 02 arteries at the same time). There is not perioperative mortality.

Conclusion: Determining the stage of the disease plays a very important role in the treatment of early-stage NSCLC. The status of metastatic lymph nodes changes during surgical assessment, with 23.4% of metastatic lymph nodes detected during surgery. Video-assisted laparoscopic lobectomy gives good results.

References
[1]
J Remon, J-C Soria et all. Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy. Ann Oncol 2021 Dec;32(12):1637-1642. Google Scholar
[2]
Manser R, Wright G et all. Surgery for early stage non-small cell lung cancer. Cochrane Database Syst Rev. 2005; Jan 25;2005(1):CD004699. Google Scholar
[3]
Detterbeck FC et al. The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung Cancer. J Thorac Oncol. 2016 Sep;11(9):1433-46. Google Scholar
[4]
William D Travis et al. Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. J Thorac Oncol. 2015 Sep;10(9):1240-1242. Google Scholar
[5]
Omar Lababede et al. The Eighth Edition of TNM Staging of Lung Cancer: Reference Chart and Diagrams. Oncologist. 2018 Jul; 23(7): 844–848. Google Scholar
[6]
Mia Schmidt-Hansen et al. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. Cochrane Database Syst Rev 2014 Nov 13;2014(11): CD009519. Google Scholar
[7]
Lee PC et al. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Ann Thorac Surg. 2007 Jul;84(1):177-81. Google Scholar
[8]
Merritt RE, Hoang CD, Shrager JB: Lymph node evaluation achieved by open lobectomy compared with thoracoscopic lobectomy for N0 lung cancer. Ann Thorac Surg 2013; 96:1171 1177. Google Scholar
[9]
Boffa DJ, Kosinski AS, Paul S, Mitchell JD, Onaitis M: Lymph node evaluation by open or video-assisted approaches in 11,500 anatomic lung cancer resections. Ann Thorac Surg 2012; 94:347–53. Google Scholar
[10]
Đỗ Kim Quế. Điều trị phẫu thuật ung thư phổi không tế bào nhỏ giai đoạn sớm: phẫu thuật mở so với phẫu thuật nội soi lồng ngực. Tạp chí y học Thành phố Hồ Chí Minh, phụ bản tập 23 số 1, 2019. Google Scholar
[11]
Gajra A et al. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol. 2003;21(6):1029. Google Scholar
[12]
Lardinois D et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg. 2006;30(5):787. Google Scholar
[13]
Sylvain Gagné et al. Modifiable risk factors for patients undergoing lung cancer surgery and their optimization: a review. J Thorac Dis. 2018 Nov; 10(Suppl 32): S3761–S3772. Google Scholar